Payment & Shipping Terms:
|Appearance:||White Powder||Package:||1kg/bag Or 25kgs/drum|
Alectinib Active Pharmaceuticals,
CAS 1256580-46-7 Active Pharmaceuticals,
Anti Tumor Active Pharmaceuticals
99% Purity CAS 1256580-46-7 Alectinib Powder Anti-Tumor Alectinib Raw Material
Alectinib is an orally available inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with antineoplastic activity. Upon administration, alectinib binds to and inhibits ALK kinase, ALK fusion proteins as well as the gatekeeper mutation ALKL1196M known as one of the mechanisms of acquired resistance to small-molecule kinase inhibitors. The inhibition leads to disruption of ALK-mediated signaling and eventually inhibits tumor cell growth in ALK-overexpressing tumor cells.
Alectinib is a highly selective and potent anaplastic lymphoma kinase (ALK) inhibitor capable of blocking the resistant gatekeeper mutant, which results in reduced cell growth. CH5424802 have been cl inically evaluated for the treatment of patients with ALK-driven tumors.
Alectinib is a second generation oral drug that selectively inhibits the activity of anaplastic lymphoma kinase (ALK) tyrosine kinase.
Contact Person: July